by Usha Govindarajulu | Mar 30, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
March 30, 2022 Latest research published in the Lancet shows diabetes onset was higher for those with post-acute sequelae or long-haul COVID-19 however these may be preliminary results. The results came from a cohort study which used databases from the United States...
by Usha Govindarajulu | Mar 16, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
March 15, 2022 In a recent article in The Scientist than appeared back in January, they mentioned using several pre-print articles which are cited for this article. In one of the pre-print articles by Adamson et al published on March 5 about a very recent small study...
by Usha Govindarajulu | Mar 2, 2022 | Biostatistics, Blog, COVID-19, Usha Govindarajulu
March 2, 2022 According to a February 28, 2022 recent article n U.S. News World based on several studies, the research is suggestive that the Wuhan China wet market was the start of the COVID-19 pandemic. The article is largely based on two pre-print studies, meaning...
by Usha Govindarajulu | Feb 17, 2022 | Biostatistics, Blog, COVID-19, Usha Govindarajulu
February 22, 2022 In a pre-print article published recently, the authors used life table and survival analyses methods to compare probability of dying from COVID-19 against probability of dying from other causes using data from the province Hubei of China, of which...
by Usha Govindarajulu | Feb 4, 2022 | Biostatistics, Blog, COVID-19, New York, Professor, Usha Govindarajulu
February 2, 2022 A recent article in the Lancet Infectious Diseases presents a large scale study of post-vaccination infection conducted in the United Kingdom to assess potential long-haul symptoms. It was a prospective, community-based, nested, case-control study...
by Usha Govindarajulu | Jan 20, 2022 | Biostatistics, Blog, COVID-19, Professor, Usha Govindarajulu
January 18, 2022 A recent article in the New England Journal of Medicine (NEJM) presents results from a large cohort study from New York State on COVID-19 vaccine effectiveness. They used data for 8,690,825 adults in New York State to assess the effectiveness of the...
